The Centers for Disease Control and Prevention (CDC), public health and regulatory officials in several states, and the U.S. Food and Drug Administration are investigating a multistate outbreak of Salmonella Uganda infections linked to whole, fresh papayas imported from Mexico and sold in Connecticut, Massachusetts, New Jersey, New York, Pennsylvania and Rhode Island.
Consumers in Connecticut, Massachusetts, New Jersey, New York, Pennsylvania, and Rhode Island who have whole, fresh papayas imported from Mexico in their homes should not eat them. Throw the papayas away, even if some of them were eaten and no one has gotten sick.
Do not eat fruit salads or other mixes that include papayas from Mexico.
If you aren’t sure the papaya you bought is from Mexico, you can ask the place of purchase. When in doubt, don’t eat the papaya. Throw it out.
Wash and sanitize places where papayas were stored: countertops and refrigerator drawers or shelves. Follow these five steps to clean your refrigerator.
The FDA strongly advises importers, suppliers, and distributors, as well as restaurants, retailers and other food service providers from all states to hold whole, fresh papayas imported from Mexico.
Public health investigators are using the PulseNet system to identify illnesses that may be part of this outbreak. PulseNet is the national subtyping network of public health and food regulatory agency laboratories coordinated by CDC. DNA fingerprinting is performed on Salmonella bacteria isolated from ill people by using techniques called pulsed-field gel electrophoresis (PFGE) and whole genome sequencing (WGS). CDC PulseNet manages a national database of these DNA fingerprints to identify possible outbreaks. WGS gives a more detailed DNA fingerprint than PFGE. WGS performed on bacteria isolated from ill people showed that they were closely related genetically. This means that ill people in this outbreak are more likely to share a common source of infection.
As of June 26, 2019, a total of 62 people infected with the outbreak strain of Salmonella Uganda have been reported from eight states.
Illnesses started on dates ranging from January 14, 2019, to June 8, 2019. Most illnesses have occurred since April 2019. Ill people range in age from 1 to 86 years, with a median age of 60. Fifty-three percent of ill people are female. Of 35 people with available information, 23 (66%) have been hospitalized. No deaths attributed to Salmonella have been reported. Of 33 ill people with available information, 22 (67%) reported being of Hispanic ethnicity.
Illnesses might not yet be reported due to the time it takes between when a person becomes ill and when the illness is reported. This takes an average of 2 to 4 weeks. Please see the Timeline for Reporting Cases of Salmonella Infection for more details.
Whole genome sequencing analysis of 40 isolates from ill people predicted antibiotic resistance to streptomycin and sulfisoxazole. Testing of three clinical isolates using standard antibiotic susceptibility testing methods by CDC’s National Antimicrobial Resistance Monitoring System (NARMS) is currently underway. This resistance will not affect the choice of antibiotic used to treat most people.
Source: CDC
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.